Historical record - last NADAC effective date: 5/29/2015

Product Information

MESTINON 60 MG/5 ML SYRUP is a brand product labeled by Bausch Health US LLC, priced at $1.9930 per ML under NDC 00187301220. Its NADAC has been published 134 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the pyridostigmine bromide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MESTINON 60 MG/5 ML SYRUP

pyridostigmine bromide
$1.9930per ML
High Outlier

Strength

60 mg/5mL

NDC

00187301220

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Effective Date

5/29/2015

Active Ingredients

PYRIDOSTIGMINE BROMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA015193

FDA Approved

Before 1982

TE Code

AA

On Market Since

1/25/1965

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for MESTINON 60 MG/5 ML SYRUP has been published 134 times since Nov 28, 2013, and over the history we have for it it has risen 330.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9930 per ML
All-time high$1.9930 (Jun 15, 2016)
All-time low$0.4625 (Nov 28, 2013)
Median price$1.5769
Average price$1.4095
Largest weekly change+30.0% (Oct 8, 2014)
Weeks tracked134
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+330.9%

Last surveyed Jun 15, 2016 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 75% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MESTINON 60 MG/5 ML SYRUP?

The current National Average Drug Acquisition Cost (NADAC) for MESTINON 60 MG/5 ML SYRUP, manufactured by Bausch Health US LLC, is $1.9930 per ML (NDC 00187301220), effective Jun 15, 2016.

How has the price of MESTINON 60 MG/5 ML SYRUP changed over time?

Over the history we have for it, the NADAC for MESTINON 60 MG/5 ML SYRUP has risen 330.9%. It has been tracked across 134 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MESTINON 60 MG/5 ML SYRUP?

Since Nov 28, 2013, the NADAC for MESTINON 60 MG/5 ML SYRUP has ranged from a low of $0.4625 (Nov 28, 2013) to a high of $1.9930 (Jun 15, 2016), with a median of $1.5769 per ML.

Are there cheaper alternatives to MESTINON 60 MG/5 ML SYRUP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PYRIDOSTIGMINE 60 MG/5 ML SOLN, is $0.5080 per ML — about 75% below MESTINON 60 MG/5 ML SYRUP.

Who manufactures MESTINON 60 MG/5 ML SYRUP?

MESTINON 60 MG/5 ML SYRUP (NDC 00187301220) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.